Share

December 14, 2021; 97 (24) Editorial

Heart Rate Controversies in Epilepsy

Autonomic Metrics and Predictions

Roland D. Thijs, Josemir W. Sander
First published October 14, 2021, DOI: https://doi.org/10.1212/WNL.0000000000012948
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
108

Share

Article Information

vol. 97 no. 24 1103-1104
DOI: 
https://doi.org/10.1212/WNL.0000000000012948
PubMed: 
34649878
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published October 14, 2021.

Article Versions

Copyright & Usage: 
© 2021 American Academy of Neurology

Author Disclosures

    1. Roland D. Thijs, MD, PhD, FRCP and
    2. Josemir W. Sander, MD, PhD, FRCP, FEAN
  1. Roland D. Thijs, MD, PhD, FRCP and
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Medtronic: speakers and travel honorarium UCB: speakers honorarium Zogenix: speakers honorarium

    Editorial Boards:

    1. Epilepsia, editorial board, 2020-now Seizure, editorial board, 2014-now Clinical Autonomic Research, editorial board, 2014-now

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Arvelle, Theravance

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Medtronic Inc. (2) New Life Wearables

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) Christelijke Vereniging voor de Verpleging van Lijders aan Epilepsie (2) The Netherlands Organisation for Health Research and Development (ZonMW; 843002707)

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Josemir W. Sander, MD, PhD, FRCP, FEAN
    3. Scientific Advisory Boards:

    1. 1) UCB Pharma - membership of Advisory Board 2) Zobenix - membership of Advisory Board 3) Arvelle - membership of Advisory Board

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. 1) Lancet Neurology - member of Editorial Board

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. 1) UCB Pharma - membership of Speakers' Bureau 2) Zogenix - membership of Speakers' Bureau 3) Eisai - membership of Speakers' Bureau 4) Arvelle - membership of Speakers' Bureau

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 1) UCB Pharma - research grant to my department

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology (R.D.T.), Leiden University Medical Centre, the Netherlands; UCL Queen Square Institute of Neurology (R.D.T., J.W.S.), London; Chalfont Centre for Epilepsy (R.D.T., J.W.S.), Chalfont St Peter, Bucks, UK; SEIN–Stichting Epilepsie Instellingen Nederland (R.D.T., J.W.S.), Heemstede, the Netherlands; and Department of Neurology (J.W.S.), West China Hospital, Sichuan University, Chengdu, China.
  1. Correspondence
    Dr. Sander l.sander{at}ucl.ac.uk
View Full Text

Article usage

Article usage: October 2021 to April 2022

AbstractFullPdfSource
Oct 20210032Highwire
Nov 2021004Highwire
Dec 20216286340Highwire
Jan 20222131917Highwire
Feb 202223233Highwire
Mar 202212416Highwire
Apr 20226186Highwire

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Alert Me